Stents and coronary artery bypass grafting (CABG) treat blocked arteries and coronary artery disease (CAD). Stents are a less invasive option, while CABG is a major surgery. Your healthcare ...

More recently, drug-eluting stents (DESs) have emerged as the predominant percutaneous strategy in patients with coronary artery disease. This Review summarizes the knowledge on coronary stenting ...

The intracranial stents market is experiencing rapid growth, fueled by the rising incidence of strokes, aneurysms, and ...

In the US, nearly two million stents are implanted every year, and they can be life-saving during a heart attack. But they may not always be the best treatment method for coronary artery disease.

The global non-vascular stents market is on track for substantial expansion, with projections indicating a market value of USD 1,408.7 million in 2025, soaring to USD 2,338.8 million by 2035.

However, it is not widely known that stents can also be placed into the blood vessels of the brain. According to experts, brain sor intracranial stenting—help open blocked arteries in the brain ...

Two innovative demonstration systems from Hahn Automation Group showcase the potential of advanced automation in medical ...

Medtronic announced that investigators enrolled the first patient in a pivotal trial of its Prevail drug-coated balloon (DCB).

India Coronary Stents Market is estimated to be valued at US$ 1,303.5 million in 2023 and is expected to exhibit a CAGR of 13.2 % by (2023-2030). Mr. Shah Coherent Market Insights Pvt. Ltd. +1 ...

Teleflex (TFX) announced it has entered into a definitive agreement to acquire substantially all of the Vascular Intervention business of ...

The global interventional cardiology devices market is on a strong growth trajectory, with a projected Compound Annual Growth ...